INFORMED: an incubator at the US FDA for driving innovations in data science and agile technology
10.1038/nrd.2018.34 2018-04-06 INFORMED: an incubator at the US FDA for driving innovations in data science and agile technology INFORMED: an incubator at the US FDA for driving innovations in data science and agile technology, Published online: 06 April 2018; doi:10.1038/nrd.2018.34Inform... |
|
The gastroesophageal cancer drug market
10.1038/nrd.2018.35 2018-04-03 The gastroesophageal cancer drug market The gastroesophageal cancer drug market, Published online: 03 April 2018; doi:10.1038/nrd.2018.35Immune checkpoint inhibitors are forecast to expand the market for gastroesophageal cancer drugs, which is particularly la... |
|
Antivirals: Topical therapy for ocular herpes
10.1038/nrd.2018.47 2018-03-28 Antivirals: Topical therapy for ocular herpes Antivirals: Topical therapy for ocular herpes, Published online: 28 March 2018; doi:10.1038/nrd.2018.47Antivirals: Topical therapy for ocular herpes |
|
Infectious disease: Virus-based tuberculosis vaccine
10.1038/nrd.2018.50 2018-03-28 Infectious disease: Virus-based tuberculosis vaccine Infectious disease: Virus-based tuberculosis vaccine, Published online: 28 March 2018; doi:10.1038/nrd.2018.50Infectious disease: Virus-based tuberculosis vaccine |
|
Immunotherapy: iPSC-based cancer vaccine
10.1038/nrd.2018.48 2018-03-28 Immunotherapy: iPSC-based cancer vaccine Immunotherapy: iPSC-based cancer vaccine, Published online: 28 March 2018; doi:10.1038/nrd.2018.48Immunotherapy: iPSC-based cancer vaccine |
|
George Yancopoulos
10.1038/nrd.2018.41 2018-03-28 George Yancopoulos George Yancopoulos, Published online: 28 March 2018; doi:10.1038/nrd.2018.41George Yancopoulos, CSO of Regeneron, discusses his 30 years at Regeneron, the company's evolving growth plans and the recent launch of a precompetitive collaborati... |
|
Neurodevelopmental disorders: CRISPR to the rescue
10.1038/nrd.2018.39 2018-03-28 Neurodevelopmental disorders: CRISPR to the rescue Neurodevelopmental disorders: CRISPR to the rescue, Published online: 28 March 2018; doi:10.1038/nrd.2018.39Neurodevelopmental disorders: CRISPR to the rescue |
|
Market watch: Upcoming market catalysts in Q2 2018
10.1038/nrd.2018.43 2018-03-28 Market watch: Upcoming market catalysts in Q2 2018 Market watch: Upcoming market catalysts in Q2 2018, Published online: 28 March 2018; doi:10.1038/nrd.2018.43Market watch: Upcoming market catalysts in Q2 2018 |
|
Sepsis: Gut bacteria induce protective IgA
10.1038/nrd.2018.49 2018-03-28 Sepsis: Gut bacteria induce protective IgA Sepsis: Gut bacteria induce protective IgA, Published online: 28 March 2018; doi:10.1038/nrd.2018.49Sepsis: Gut bacteria induce protective IgA |
|
Drug delivery: DNA nanorobots — seek and destroy
10.1038/nrd.2018.40 2018-03-28 Drug delivery: DNA nanorobots — seek and destroy Drug delivery: DNA nanorobots — seek and destroy, Published online: 28 March 2018; doi:10.1038/nrd.2018.40Drug delivery: DNA nanorobots — seek and destroy |